Inflammation is the driving mechanism in the pathophysiology of cancer sarcopenia, and different inflammatory markers are related to sarcopenia, such as C-reactive protein (CRP) and the neutrophil-to lymphocyte ratio. This evidence concerns the gene CRP and sarcopenia.